NCT00485953View on ClinicalTrials.gov

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Bone LossOsteoporosisBreast Cancer
Interventions
DRUG

risedronate

risedronate 35 mg per week

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

Susan L. Greenspan

OTHER

NCT00485953 - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy | Biotech Hunter | Biotech Hunter